Current Views on Pathophysiology and Potential Therapeutic Targets in Sjögren's Syndrome: A Review from the Perspective of Viral Infections, Toll-like Receptors, and Long-Noncoding RNAs.

In contrast, the therapeutic effects of FLG on active SS, another class of JAKi, have already been studied in a randomized double-blind, placebo-controlled study, which did not reach statistical significance [ 89 ].

also in 111,027 other papers